All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
Results
2 results
Evidence gaps for drugs and medical devices at market entry in Europe and potential solutions
KCE Reports 347C (2021)
To obtain marketing authorisation for the European market, any new product must provide evidence of its quality, safety and efficacy. For high-risk medical devices (e.g. implants), the requirements are less strict.
Read more
Towards a better managed off-label use of drugs
KCE Reports 252C (2015)
Read more